OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology Neurosurgery and Psychiatry is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
091 The East London Parkinson’s disease project – engaging a diverse population in research	145
175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data	136
102 Levodopa and melanoma what do clinicians think?	113
117 Who is the culprit – the virus or the anti-virus?	111
Haemorrhagic myelitis as a manifestation of MOG antibody-associated disease	94
35 Processing speed (PS) improvement in alcohol related brain damage (ARBD)	91
086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes	85
West is best – a strongman with numb feet	83
059 Cannabidiol in refractory adult epilepsies: broadening the Lennox-Gastaut phenotype?	79
12 A pilot investigation of interoceptive accuracy, awareness, and sensibility in functional neurological disorder	79
101 Motor and non-motor features of prodromal PD	77
Neural (re)organisation of language and memory: implications for neuroplasticity and cognition	67
DNA methylation profiling in central nervous system tumours	65
Discrepancies between patient-reported and physician-reported severity and disability in functional and non-functional movement disorders	60
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning	59
Visuospatial working memory in Huntington’s disease: behavioural and structural brain correlates	57
Early treatment of type II SMA slows rate of progression of scoliosis	57
Navigating the presymptomatic frontier in genetic ALS and FTD	56
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression	55
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis	55
Exploring the role of focused ultrasound in neurosurgery and neuro-oncology	54
Improved naming in patients with Broca’s aphasia with tDCS	53
High frequency ofHTRA1ANDABCC6mutations in Japanese patients with adult-onset cerebral small vessel disease	50
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort	50
Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy	50

Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis	49
40 Temporal discounting and male depression	48
The Scottish Epilepsy Deaths Study Score (SEDS Score): a risk prediction model for epilepsy-related deaths	47
052 SKYLINE study design efficacy and safety of gantenerumab in participants at-risk for Alzheimer’s disease	46
Evaluation of MDS-PSP diagnostic criteria in a combined behavioural neurology and atypical parkinsonism service	44
055 Assessment of MACE cognitive screener using efficiency indexes	44
005 A case of xanthomatous hypophysitis presenting as recurrent pituitary adenoma	44
178 Motor neurone disease and sociodemographic factors: a review	44
009 Asymmetric peri-optic cerebrospinal fluid space distension in cluster headache	44
106 Critical ischaemia without infarction presenting as progressive hemichorea: a case study and literature review	43
132 Adverse prognostic factors predicting disease modifying therapies in MS: a real- world cohort	42
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology	41
Patients with symmetric Parkinson’s disease do poorly with subthalamic stimulation	41
CIDP trials and tribulations	39